Skip to main content
Clinical Trials/NCT03723980
NCT03723980CompletedPhase 3

Effect of Propolis Paste as Intracanal Medicament on Post-Endodontic Pain: a Double-Blind Randomized Clinical Trial.

Juzer Shabbir Saifee1 site in 1 country80 target enrollmentStarted: November 16, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
Pain Intensity Measure: Visual Analogue Pain Scale

Study Overview

Brief Summary

This study evaluates the role of propolis paste as compared to calcium hydroxide (when used as intracanal medication) in prevention and treatment of pain after root canal treatment in necrotic (infected) teeth. Half of the participants will receive calcium hydroxide, while the other half will receive propolis.

Detailed Description

Propolis is a developing herbal medicament used in various aspects on dentistry. it is extremely biocompatible; has flavanoids; which acts as anti-inflammatory and antimicrobial components.

Calcium hydroxide is a synthetic medication which is antibacterial

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
20 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Single rooted Necrotic teeth with symptomatic or asymptomatic periapical periodontitis having periapical widening or radiolucency without bone expansion (PAI index 2, 3 and 4).
  • Teeth with favorable root morphology.
  • Teeth with closed apex.

Exclusion Criteria

  • Teeth with PAI index 1 and
  • Patients who are on antibiotics.
  • Patient with recent trauma to the jaw.
  • Teeth with open apex
  • Multi-rooted teeth.
  • Vital teeth.
  • Non-restorable teeth.
  • Unfavorable root morphology (severely curved, dilacerated, severely sclerosed or obliterated).
  • Teeth associated with soft tissue abscess or swelling.
  • Teeth with external or internal root resorption
  • Re-treatment cases.
  • Periodontally compromised teeth (like mobile teeth and teeth with excessive bone loss).
  • Teeth requiring endodontic surgery.
  • Teeth requiring non-surgical endodontic treatment of multiple teeth in the same or opposing quadrant.
  • Medically compromised patients (ASA-III and above), patients with special communication needs or who doesn't understand Urdu or English language.
  • Patients allergic to bee pollen or honey products.

Arms & Interventions

Control Group or Group I or Calcium hydroxide Group

Active Comparator

Intervention: Calcium Hydroxide (Drug)

Experimental Group or Group II or Propolis Group

Experimental

Intervention: Propolis (Drug)

Outcomes

Primary Outcomes

Pain Intensity Measure: Visual Analogue Pain Scale

Time Frame: 4 hours, 12 hours, day 2, day 3 and day 4

Self recorded pain intensity by the patients at 4 hours, 12 hours, day 2, day 3 and day 4 after root canal preparation and intracanal medicament insertion (first visit). Pain intensity recorded on a Visual Analogue Scale from 0 to 100. Patients who experience no or mild pain; and do not require analgesic will record their pain intensity from 0 to 24. Patients who experience moderate pain; and require Over-the-counter analgesic will record pain intensity from 25 to 49. Patients who experience severe pain; and require use of codeine containing medicine will record their pain intensity from 50 to 74. Patients who experience extreme pain, and no medicine is able to relieve their pain will record pain intensity from 75 to 100. lower pain score (intensity) is a better outcome as compared to higher pain intensity (score)

Secondary Outcomes

  • Acute Increase in Pain Score (Acute Exacerbation of Pain)(4 hours, 12 hours, day 2, day 3, and day 4)
  • Difference of Pain Score Between Different Time Intervals(4 hours, 12 hours, day 2, day 3, and day 4)

Investigators

Sponsor
Juzer Shabbir Saifee
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Juzer Shabbir Saifee

Principal Investigator

Dow University of Health Sciences

Study Sites (1)

Loading locations...

Similar Trials